CIK 0001347178 · Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 030491827
- Phone
- 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-06 | Polymeropoulos Mihael Hristos President and CEO | Option exercise | +75,365 | $3.12 | $235K | 1,455,116 |
| 2022-12-06 | Polymeropoulos Mihael Hristos President and CEO | Sale | −48,250 | $10.61 | $512K | 1,406,866 |
| 2022-12-06 | Polymeropoulos Mihael Hristos President and CEO | Option exercise · Stock Option (Right to Buy) | −75,365 | 0 | ||
| 2022-12-06 | Moran Kevin Patrick SVP, CFO & Treasurer | Option exercise | +7,500 | $3.12 | $23K | 124,952 |
| 2022-12-06 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −4,792 | $10.61 | $51K | 120,160 |
| 2022-12-06 | Moran Kevin Patrick SVP, CFO & Treasurer | Option exercise · Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2022-12-05 | Polymeropoulos Mihael Hristos President and CEO | Option exercise | +74,635 | $3.12 | $233K | 1,427,401 |
| 2022-12-05 | Polymeropoulos Mihael Hristos President and CEO | Sale | −47,650 | $10.62 | $506K | 1,379,751 |
| 2022-12-05 | Polymeropoulos Mihael Hristos President and CEO | Option exercise · Stock Option (Right to Buy) | −74,635 | 75,365 | ||
| 2022-08-26 | Birznieks Gunther SVP, Business Development | Option exercise | +1,250 | $3.12 | $4K | 190,057 |
| 2022-08-26 | Birznieks Gunther SVP, Business Development | Option exercise · Employee Stock Option (Right to Buy) | −1,250 | 0 | ||
| 2022-08-22 | Wijkstrom Joakim SVP, Chief Marketing Officer | Sale | −3,605 | $10.27 | $37K | 96,673 |
| 2022-08-15 | Williams Timothy SVP & General Counsel | Sale | −3,689 | $10.42 | $38K | 100,162 |
| 2022-08-15 | Williams Timothy SVP & General Counsel | Sale | −4,611 | $10.21 | $47K | 95,551 |
| 2022-07-28 | Moran Kevin Patrick SVP, CFO & Treasurer | Sale | −2,239 | $10.97 | $25K | 117,452 |
| 2022-06-16 | Ward Anne Sempowski Director | Grant or award | +12,006 | 22,006 | ||
| 2022-06-16 | Ward Anne Sempowski Director | Grant or award · Stock Option (right to buy) | +24,707 | 24,707 | ||
| 2022-06-16 | Mitchell Stephen Ray Director | Grant or award | +12,006 | 18,521 | ||
| 2022-06-16 | Mitchell Stephen Ray Director | Grant or award · Stock Option (right to buy) | +24,707 | 24,707 | ||
| 2022-06-16 | DUGAN RICHARD W Director | Grant or award | +12,006 | 80,393 |
Page 7 of 8 · 153 trades